Understanding chronic rhinosinusitis and its treatment options
Official title: Mentoring in Chronic Rhinosinusitis Pathophysiology and Mechanisms of Disease
Funded at University of Alabama at Birmingham · NIH-11138197 · Data updated 2026-11-12
This study is looking at chronic rhinosinusitis (CRS) to understand how different types of inflammation affect patients, so we can create better, personalized treatments just for you, while also helping train future doctors in this area.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Alabama at Birmingham NIH-funded |
| Lab location | 1 site (Birmingham, United States) |
| Project start | July 12, 2023 |
| Project end | June 30, 2028 |
| Funding year | 2024 |
| Award (this year) | $115,969 |
| NIH project number | 7K24AI177947-02 |
| Project ID | NIH-11138197 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who are diagnosed with chronic rhinosinusitis.
✕Less likely to help
Patients with acute sinusitis or those under 21 years old may not benefit from this research.
What this research studies
This research investigates chronic rhinosinusitis (CRS), a common inflammatory condition that significantly impacts patients' quality of life. The study aims to identify different inflammatory patterns in CRS patients to develop personalized treatment pathways. By enrolling patients and analyzing their biospecimens, researchers will assess how inflammatory markers and microbial communities change over time and how these changes relate to treatment outcomes. The project also emphasizes mentoring future clinician-scientists in the field of rhinology.
Why it matters
Potential benefit: If successful, this research could lead to more effective, personalized treatments for chronic rhinosinusitis, improving patients' quality of life.
How similar studies have gone: Previous research has shown promise in understanding chronic rhinosinusitis through similar approaches, indicating potential for meaningful advancements.
Where this research is happening
-
University of Alabama at Birmingham
Birmingham, United States Active
Researchers
- Principal investigator: Turner, Justin H — University of Alabama at Birmingham
- Study coordinator: Turner, Justin H
Related research
Other NIH-funded projects on the same topics.
-
IOP and CSF Pressure in Glaucoma Risk
This grant studies how eye pressure and cerebrospinal fluid pressure together influence glaucoma risk and vision loss.
-
Exploring how Down syndrome affects optic nerve health in kids
A study using a mouse model to understand why optic nerve problems are common in children with Down syndrome and how to prevent them.
-
Global bromocriptine trial for postpartum cardiomyopathy
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with peripartum cardiomyopathy.
-
Global Bromocriptine Add-on for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding the dopamine agonist bromocriptine to standard heart failure care helps postpartum women with a specific heart condition.
-
Global Bromocriptine Trial for Postpartum Heart Failure (GLOBal PPCM)
A large international study will test whether adding bromocriptine to standard heart-failure care helps women with postpartum cardiomyopathy.
-
Bromocriptine as add-on therapy for postpartum cardiomyopathy across multiple sites
A large international study will test whether adding bromocriptine to standard heart failure treatment helps new mothers with postpartum cardiomyopathy.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.